Current Consultations

Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.

The following lists both consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia updates this regularly but we may not participate in every one listed.

If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia via email greg.mullins@researchaustralia.org.

Please click the heading in the left hand column to access consultation information from the relevant website.

Consultation

Details

Higher Education Research Commercialisation IP Framework

 

Due 18 October 10am AEDT (not 10am AEST as shown on the webpage)

 As previously announced, the Government is scoping a University Research Commercialisation Scheme to better translate and commercialise university research outputs.

As part of this work the Minister for Education has announced a plan to develop a Higher Education Research Commercialisation IP Framework, to ‘provide a trusted foundation for collaboration and remove barriers to negotiation and commercialisation.’ It will make the use of standard contracts developed by the Department mandatory for the commercialisation of research that has received ARC funding, with a view to later extending this to NHMRC funded projects.

Interested parties and members of the public are invited to contribute their perspectives on the development of an IP Framework. The rationale, scope, and design elements of an IP Framework are outlined in a consultation paper.

 

National Obesity Prevention Strategy

 

Due 3 November

 The Department of Health is undertaking a consultation on the Draft National Obesity Prevention Strategy 2022-32.

‘Research and Evidence’ is recognised as an enabler of the strategy and accessing ‘research and development funding to grow the evidence base, reduce gaps in knowledge and assess promising approaches to prevent obesity in the community’ is identified as an action.

Comments on the Draft Strategy are sought by electronic survey.

Primary Health Care 10 Year Plan

 

Due 9 November 2021

 The Department of Health is undertaking a consultation on a draft Primary Health Care 10 Year Plan.

The Plan has been developed with input from the Primary Care Steering Group, and makes several references to how research can be incorporated as part of the plan to support better delivery of primary care in the next decade.

The draft Plan and supporting documents are available from the website, and responses can be provided via an electronic survey.

Queensland Innovation Places Strategy

 

 

Due 26 November

 As part of Queensland’s Economic Recovery, the Government is looking for opportunities to grow the state’s innovation places.

It wants to build and enhance opportunities and partnerships across industry, businesses, universities, startups, investors and other stakeholders.

A discussion paper is available to guide the consultation, with responses able to be provided via an electronic survey or written submission.

‘National One-Stop-Shop’ consultations for health and medical research platform

 The Australian Commission on Safety and Quality in Healthcare is conducting consultations on a national online portal for all health and medical research which will make it easier for researchers, industry representatives and sponsors to find, conduct, participate and invest in research in Australia.

The concept for the National One-Stop-Shop seeks to achieve a national, interconnected, rapid and streamlined approvals platform that will:

    • include a cross-jurisdictional ethics and governance approvals platform that incorporates key application, notification and approval systems
    • incorporate the Clinical Trials Notification and Clinical Trials Approval schemes administered by the Therapeutic Goods Administration (TGA)
    • include an embedded and automated next-generation national clinical trials registry
    • provide sophisticated monitoring and reporting functionality for different users.

Register your interest to get updates on the consultations and how you can be involved.

Select Committee on COVID-19

 

 

 On 8 April 2020, the Senate resolved to establish a Select Committee on COVID-19 to inquire into the Australian Government’s response to the COVID-19 pandemic.

The terms of reference are very broad:

    1. the Australian Government’s response to the COVID-19 pandemic; and
    2. any related matters.

Research Australia has made a submission to the Inquiry, which is available here.

The Committee is to present its final report on or before 30 June 2022.